Immuno-Oncology Discovery from Bristol-Myers Squibb published in Nature
Immuno-Oncology Discovery from Bristol-Myers Squibb published in Nature
„Vista is an acidic pH selective ligand for PSGL-1“
Identification of a new immune-oncology drug target using the LRC-TriCEPS platform on primary human T-cells.
2019-10-30T06:05:00+00:00
https://www.dualsystems.com/testimonials/immuno-oncology-discovery-from-bristol-myers-squibb-published-in-nature/
